Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mutation-guided therapeutics.

Science (New York, N.Y.) - 8 Apr 2022

Douglass Jacqueline

Abstract excerpt

Development of bispecific antibodies to target mutant peptides in cancer.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Bispecific
Share to Immunotherapy
Share to Mutation
Share to Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35389812
DOI: 10.1126/science.abo4237

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mutation-guided therapeutics.PMID 35389812Read ↗

Targeting cancer with bispecific antibodies.Semantic proximity Read ↗

Principles and Current Clinical Landscape of Multispecific Antibodies against CancerSemantic proximity Read ↗

Mutation-Derived Tumor Antigens: Novel Targets in Cancer Immunotherapy.Semantic proximity Read ↗

Discovery and Subtyping of Neo-Epitope Specific T-Cell Responses for Cancer Immunotherapy: Addressing the Mutanome.Semantic proximity Read ↗

Deep mutational scanning for therapeutic antibody engineeringSemantic proximity Read ↗

Genetic alteration of a bispecific ligand-directed toxin targeting human CD19 and CD22 receptors resulting in improved efficacy against systemic B cell malignancySemantic proximity Read ↗

Cancer therapy via neoepitope-specific monoclonal antibody cocktailsSemantic proximity Read ↗

Bispecific antibodies for immune cell retargeting against cancerSemantic proximity Read ↗

Target Mutation-Driven Drug Discovery.Semantic proximity Read ↗

Mutanome directed cancer immunotherapy.Semantic proximity Read ↗

Bioengineering a unique deimmunized bispecific targeted toxin that simultaneously recognizes human CD22 and CD19 receptors in a mouse model of B-cell metastases.Semantic proximity Read ↗

Mutation-specific T cells for immunotherapy of gliomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.